TrialHaematologica2016

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study.

Massimo Federico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.